Resp-IoT: IoT device for evaluation of respiratory risk from COVID-19

  • Funded by Royal Academy of Engineering (RAENG)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2021
  • Known Financial Commitments (USD)

    $25,423.93
  • Funder

    Royal Academy of Engineering (RAENG)
  • Principal Investigator

    Paulo Camilo Alberto Vela Anton
  • Research Location

    Peru
  • Lead Research Institution

    Universidad Peruana Cayetano Heredia
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Prognostic factors for disease severity

  • Special Interest Tags

    Data Management and Data SharingDigital Health

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

80% of patients of COVID-19 are mild cases, which means they require outpatient care. However, they can quickly develop acute respiratory complications. Countless patients will not have the opportunity for constant monitoring due to a shortage of human resources in health, as well as the evident collapse of the health system, especially those in low-and-middle-income countries. The respiratory rate is an important prognostic factor that can be identified early. Its constant and reliable monitoring will allow a better control of the evolution of the patient for a timely attention. The proposed solution is a hardware-based monitoring system with Internet of Things (IoT) technology, with the ability to obtain parameters such as respiratory rate, heart rate and oxygen saturation, as well as a progressive web app for storage and setting. In addition, we will develop an electronic patient diary to collect symptoms, applying statistics to the collected values through a cloud platform. Collecting and analyzing this big data could facilitate the future development of prediction algorithms. Healthcare companies could use this technology to provide transparency in their overall information system. This will enhance the COVID-19 patient management and treatment workflow with an efficient performance for decision making in complex cases.